Daily Cosmetic Research Analysis
Analyzed 4 papers and selected 3 impactful papers.
Summary
Analyzed 4 papers and selected 3 impactful articles.
Selected Articles
1. Keratinocyte-derived exosomes serve as an active messenger platform for LINC01605 to amplify TGF-β1-induced fibroblasts activation.
The study shows that TGF-β1-stimulated keratinocytes release exosomes enriched with linc01605, which, when taken up by dermal fibroblasts, increase proliferation, migration and COL1A1 expression via sponging miR-370-3p and upregulating TGFBR2—amplifying TGF-β1/Smads signaling and promoting profibrotic phenotypes.
Impact: Identifies a novel exosome-mediated lincRNA mechanism amplifying canonical TGF-β signaling in hypertrophic scarring, providing specific molecular targets (linc01605/miR-370-3p/TGFBR2) for anti-fibrotic intervention.
Clinical Implications: Provides mechanistic targets (linc01605, miR-370-3p, TGFBR2) that could be pursued for topical or molecular anti-fibrotic therapies to prevent or reduce hypertrophic scarring after skin injury or cosmetic procedures; requires translation to in vivo models and safety assessments.
Key Findings
- TGF-β1-stimulated keratinocyte-derived exosomes have increased profibrotic activity on human dermal fibroblasts.
- Exosomal linc01605 is the primary mediator that, by sponging miR-370-3p, upregulates TGFBR2 expression.
- This mechanism amplifies canonical TGF-β1/Smads signaling, increasing proliferation, migration and COL1A1 expression in fibroblasts.
Methodological Strengths
- Mechanistic dissection identifying specific lincRNA–miRNA–receptor axis
- Functional assays demonstrating effects on proliferation, migration and collagen expression
Limitations
- Abstract does not state in vivo validation or therapeutic modulation experiments
- Sample sizes and reproducibility details (biological replicates) are not provided in abstract
Future Directions: Validate findings in animal models of hypertrophic scarring, test therapeutic inhibition of linc01605 or delivery of miR-370-3p mimics, and assess safety/effect on wound healing.
Hypertrophic scarring (HS) represents a proliferative disorder that emerges due to aberrant wound healing processes and is characterized by the excessive accumulation of extracellular matrix components. Recent research has highlighted the pivotal role of exosomes-nanoscale extracellular vesicles-as crucial mediators of intercellular communication in both tissue repair and pathological states. This study investigates the mechanism by which TGF-β1 modulates the cargo of keratinocyte-derived exosomes to promote the transfer of the long non-coding RNA linc01605. The results reveal that exosomes secreted by TGF-β1-stimulated keratinocytes exhibit heightened profibrotic activity. Upon internalization by human dermal fibroblasts (HDFs), these exosomes markedly enhance cellular proliferation, migration, and collagen I (COL1A1) expression. linc01605, encapsulated within these exosomes, has been identified as the primary molecular mediator. Mechanistically, linc01605 functions as a competitive endogenous RNA that binds miR-370-3p, thereby alleviating the repression of TGFBR2 expression and amplifying the canonical TGF-β1/Smads signaling pathway. In summary, this work elucidates a novel pathogenic pathway in which TGF-β1-induced keratinocyte-derived exosomes mediate the delivery of HS-associated linc01605 to drive fibrosis. These findings not only clarify a fundamental mechanism underlying HS pathogenesis but also reveal potential therapeutic targets for the development of innovative anti-fibrotic strategies.
2. Metabolic engineering of Saccharomyces cerevisiae sphingolipid pathways for enhanced phytoceramide production.
Using targeted genetic changes (SUR2 overexpression, SCS7 deletion, ISC1 overexpression) and lipidomics, the authors achieved up to a 15-fold increase in phytoceramide abundance (scs7Δ) and raised phytoceramide proportion of the ceramide pool from 5% to as high as 75% in engineered strains, demonstrating routes for scalable phytoceramide production in yeast.
Impact: Demonstrates concrete genetic modifications that substantially enrich phytoceramides in S. cerevisiae and provides comprehensive lipidomic characterization—advancing potential scalable production of a high-value cosmetic ingredient.
Clinical Implications: Indirect for clinical practice; major translational implication is enabling scalable, potentially cost-effective sources of phytoceramides for dermatologic and cosmetic formulations, which could influence product availability and clinical studies of barrier-restoring therapies.
Key Findings
- scs7Δ strain produced a 15-fold increase in phytoceramide abundance compared with wild type.
- Phytoceramide proportion of the quantified ceramide pool increased from 5% (wild type) to 46% (SUR2-OE) and 75% (scs7Δ).
- Combined scs7Δ SUR2-OE strain did not show additive effects; residual hydroxylated ceramides suggest intrinsic regulatory constraints.
Methodological Strengths
- Integrated genetic engineering with comprehensive lipidomic profiling enabling quantitative assessment.
- Multiple genetic strategies tested (overexpression and deletion) with clear comparative data.
Limitations
- Abstract does not report yields in mass units or scalability metrics for industrial production.
- No information on downstream purification, functional testing of produced phytoceramides, or in vivo efficacy/safety.
Future Directions: Optimize fermentation scale-up and downstream purification, measure absolute yields and cost-effectiveness, and test biological activity/safety of yeast-derived phytoceramides in skin models and clinical formulations.
Phytoceramides are essential sphingolipids that support skin barrier integrity and hydration, making them valuable for cosmetic and pharmaceutical applications. However, their intricate structures and low natural abundance pose significant challenges for scalable production. Here, we present an integrated metabolic engineering and lipidomics study aimed at enhancing phytoceramide production in Saccharomyces cerevisiae. We implemented three strategies: (i) overexpression of SUR2 (sphinganine C4-hydroxylase) to boost phytosphingolipid formation; (ii) deletion of SCS7 (ceramide α-hydroxylase) to redirect flux toward non-hydroxylated phytoceramides; and (iii) overexpression of ISC1 (inositol phosphosphingolipid phospholipase) to recycle complex sphingolipids into ceramide pools. SUR2 overexpression showed the highest transcript levels, whereas lipidomics revealed that scs7Δ produced the highest phytoceramide enrichment with a 15-fold increase in phytoceramide abundance relative to the wild type. In terms of relative abundance within the quantified ceramide pool, phytoceramides increased from 5% in wild type to 46% in the SUR2-OE strain and 75% in the scs7Δ strain. The combined scs7Δ SUR2-OE strain did not exhibit additive metabolic effects on the lipid profile. The presence of residual hydroxylated ceramides indicated intrinsic regulatory constraints, aligning with the bypass mechanism proposed here whereby ceramide synthases can use pre-hydroxylated acyl-CoA. Importantly, this work contributes a comprehensive lipidomic profiling of S. cerevisiae, enabling clear discrimination between engineered and wild type strains and identification of genotypes exerting the greatest impact on phytoceramide accumulation. This approach advances sphingolipid pathway modulation and positions S. cerevisiae as a valuable model for studying phytoceramide-focused remodeling.
3. Symblepharon Release and Fornix Reconstruction after Ocular Chemical Injury: Outcomes from a Decade-Long Clinical Experience.
In a retrospective series of 125 fornices (118 patients) undergoing SR-FR for chemical injury-related symblepharon, anatomical success was 61.6% after first surgery and 84.8% after final reconstruction. Higher symblepharon grade predicted worse outcomes and need for repeat surgery; delayed epithelial healing independently predicted poorer anatomical results. Visual improvement depended on ocular comorbidities rather than anatomical success.
Impact: Provides large, clinically actionable data identifying severity and epithelial healing as predictors of anatomical success after fornix reconstruction, informing surgical planning and postoperative monitoring in ocular chemical injuries.
Clinical Implications: Use symblepharon grade to counsel patients and plan for potential staged reconstructions; monitor epithelial healing closely as early indicator of outcome and consider interventions to promote epithelialisation to improve anatomical success rates.
Key Findings
- Anatomical success after SR-FR was 61.6% after first procedure and 84.8% after final reconstruction.
- Higher symblepharon grade independently predicted poorer anatomical outcomes (multivariate p=0.005).
- Delayed epithelial healing independently associated with worse anatomical outcome (p=0.011); age, gender, chemical type, mitomycin‑C use and fornix-forming sutures were not significant predictors.
Methodological Strengths
- Large sample across 10-year period at a tertiary center with multivariate analysis to identify independent predictors.
- Clear, clinically relevant outcome definitions (success/partial success/failure) and follow-up median provided.
Limitations
- Retrospective design with inherent selection and information biases.
- Follow-up median 15 months; longer-term functional/cosmetic outcomes beyond study period may differ.
Future Directions: Prospective studies to test interventions that accelerate epithelial healing and randomized comparisons of adjunctive strategies to improve primary success rates; longer-term patient-centered outcome measurement.
PURPOSE: To evaluate anatomical, visual and cosmetic rehabilitation outcomes of symblepharon release with fornix reconstruction (SR-FR) in eyes with chronic chemical injury and identify factors influencing surgical success. METHODS: Retrospective observational study of patients undergoing SR-FR for chemical injury-related symblepharon over 10 years at a tertiary eye care centre. Symblepharon severity, surgical techniques, epithelial healing and demographics were recorded. Anatomical (success, partial success and failure), visual rehabilitation and cosmetic rehabilitation outcomes were analysed. Multivariate ordinal logistic regression identified factors associated with anatomical outcome. RESULTS: The study involved 125 fornices in 118 patients. Median age at injury was 7 years (IQR 4-19) and at SR-FR 12 years (IQR 5-24), with a median follow-up of 15 months (IQR 8-36). Successful anatomical outcome was achieved in 61.6% after the first procedure, increasing to 84.8% after final reconstruction. Severe symblepharon was associated with lower success rates and greater need for repeat attempts (p=0.027). On multivariate analysis, symblepharon grade was an independent predictor of anatomical outcome (p=0.005), while epithelial healing was associated with improved outcome (p=0.046); delayed epithelial healing was independently associated with poorer outcome (p=0.011); age, gender, chemical type, mitomycin-C use and fornix-forming sutures were not significant. Visual improvement was independent of anatomical success and primarily limited by ocular comorbidities. CONCLUSIONS: SR-FR is an effective approach for anatomical restoration. Symblepharon severity is an independent predictor of outcome, while delayed epithelialisation is a clinically relevant early postoperative indicator of poorer outcomes. Visual recovery is largely determined by associated ocular comorbidities.